{"date":"2026-05-20","count":69,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-4743-2026-05-20-2108-19sw3wi","company_id":"4743","company":"合一","market":"上櫃","industry":"生技醫療","date":"2026-05-20","time":"21:08:50","subject":"本公司新藥上市後臨床試驗(計畫編號:ON101CLCT06)，今日依計畫書完成療效分析，因安全性良好、顯著療效，外部獨立數據監察委員會(IDMC)建議提前終止試驗。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合一（4743），2026-05-20 21:08，「本公司新藥上市後臨床試驗(計畫編號:ON101CLCT06)，今日依計畫書完成療效分析，因安全性良好、顯著療效，外部獨立」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4128-2026-05-20-2054-yshhok","company_id":"4128","company":"中天","market":"上櫃","industry":"生技醫療","date":"2026-05-20","time":"20:54:07","subject":"公告子公司中天(上海)生物科技有限公司新藥上市後臨床試驗(計畫編號:ON101CLCT06)，今日依計畫書完成療效分析，因安全性良好、顯著療效，外部獨立數據監察委員會建議提前終止試驗。","clause":"第53款","fact_date":"2026-05-20","cite_as":"公開資訊觀測站重大訊息：中天（4128），2026-05-20 20:54，「公告子公司中天(上海)生物科技有限公司新藥上市後臨床試驗(計畫編號:ON101CLCT06)，今日依計畫書完成療效分析，」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6955-2026-05-20-1912-11is1wt","company_id":"6955","company":"邦睿生技-創","market":"上市","industry":"生技醫療","date":"2026-05-20","time":"19:12:25","subject":"公告本公司115年股東常會通過解除董事及其代表人競業禁止","clause":"第21款","fact_date":"2026-05-20","cite_as":"公開資訊觀測站重大訊息：邦睿生技-創（6955），2026-05-20 19:12，「公告本公司115年股東常會通過解除董事及其代表人競業禁止」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6955-2026-05-20-1910-1jb8ii5","company_id":"6955","company":"邦睿生技-創","market":"上市","industry":"生技醫療","date":"2026-05-20","time":"19:10:53","subject":"公告本公司115年股東常會重要決議事項","clause":"第18款","fact_date":"2026-05-20","cite_as":"公開資訊觀測站重大訊息：邦睿生技-創（6955），2026-05-20 19:10，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7878-2026-05-20-1830-1rpivf9","company_id":"7878","company":"藥祇","market":"興櫃","industry":"生技醫療","date":"2026-05-20","time":"18:30:46","subject":"(更正)公告本公司115年股東常會通過解除本公司新任董事競業禁止限制","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：藥祇（7878），2026-05-20 18:30，「(更正)公告本公司115年股東常會通過解除本公司新任董事競業禁止限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7878-2026-05-20-1830-bq7mfj","company_id":"7878","company":"藥祇","market":"興櫃","industry":"生技醫療","date":"2026-05-20","time":"18:30:04","subject":"(更正)公告本公司115年股東常會改選董事(含獨立董事)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：藥祇（7878），2026-05-20 18:30，「(更正)公告本公司115年股東常會改選董事(含獨立董事)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-5312-2026-05-20-1755-7nyl1g","company_id":"5312","company":"寶島科","market":"上櫃","industry":"生技醫療","date":"2026-05-20","time":"17:55:44","subject":"代重要子公司寶崴光學(股)公司公告股利分派事宜","clause":"第14款","fact_date":"2026-05-20","cite_as":"公開資訊觀測站重大訊息：寶島科（5312），2026-05-20 17:55，「代重要子公司寶崴光學(股)公司公告股利分派事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6945-2026-05-20-1748-1bci5gk","company_id":"6945","company":"圓祥生技","market":"上櫃","industry":"生技醫療","date":"2026-05-20","time":"17:48:02","subject":"公告本公司第二屆審計委員會推選召集人","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：圓祥生技（6945），2026-05-20 17:48，「公告本公司第二屆審計委員會推選召集人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6945-2026-05-20-1747-1a498cr","company_id":"6945","company":"圓祥生技","market":"上櫃","industry":"生技醫療","date":"2026-05-20","time":"17:47:21","subject":"公告本公司第二屆審計委員會名單","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：圓祥生技（6945），2026-05-20 17:47，「公告本公司第二屆審計委員會名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6945-2026-05-20-1746-7d728n","company_id":"6945","company":"圓祥生技","market":"上櫃","industry":"生技醫療","date":"2026-05-20","time":"17:46:18","subject":"公告本公司第二屆薪資報酬委員會推選召集人","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：圓祥生技（6945），2026-05-20 17:46，「公告本公司第二屆薪資報酬委員會推選召集人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6945-2026-05-20-1745-cl6l84","company_id":"6945","company":"圓祥生技","market":"上櫃","industry":"生技醫療","date":"2026-05-20","time":"17:45:14","subject":"公告本公司董事會決議通過委任第二屆薪資報酬委員會委員","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：圓祥生技（6945），2026-05-20 17:45，「公告本公司董事會決議通過委任第二屆薪資報酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6945-2026-05-20-1743-9769qc","company_id":"6945","company":"圓祥生技","market":"上櫃","industry":"生技醫療","date":"2026-05-20","time":"17:43:38","subject":"公告本公司董事會選任董事長","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：圓祥生技（6945），2026-05-20 17:43，「公告本公司董事會選任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6945-2026-05-20-1737-2kbcuz","company_id":"6945","company":"圓祥生技","market":"上櫃","industry":"生技醫療","date":"2026-05-20","time":"17:37:12","subject":"公告本公司115年股東常會決議通過解除董事及其代表人競業禁止限制案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：圓祥生技（6945），2026-05-20 17:37，「公告本公司115年股東常會決議通過解除董事及其代表人競業禁止限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2026-05-20-1734-h0s4my","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2026-05-20","time":"17:34:04","subject":"本公司新藥CBL-514注射劑用於減少腹部皮下脂肪之第二個多國多中心樞紐三期臨床試驗CBL-0302申請，今日已完成澳洲主管機關HREC送件","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2026-05-20 17:34，「本公司新藥CBL-514注射劑用於減少腹部皮下脂肪之第二個多國多中心樞紐三期臨床試驗CBL-0302申請，今日已完成澳洲」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6945-2026-05-20-1733-xmx23a","company_id":"6945","company":"圓祥生技","market":"上櫃","industry":"生技醫療","date":"2026-05-20","time":"17:33:22","subject":"公告本公司115年股東常會改選董事(含獨立董事)當選名單","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：圓祥生技（6945），2026-05-20 17:33，「公告本公司115年股東常會改選董事(含獨立董事)當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4724-2026-05-20-1731-1c6zp0i","company_id":"4724","company":"宣捷幹細胞","market":"興櫃","industry":"生技醫療","date":"2026-05-20","time":"17:31:52","subject":"公告本公司第三屆薪資報酬委員會委員名單","clause":"第6款","fact_date":"2026-05-20","cite_as":"公開資訊觀測站重大訊息：宣捷幹細胞（4724），2026-05-20 17:31，「公告本公司第三屆薪資報酬委員會委員名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4724-2026-05-20-1731-8ysypv","company_id":"4724","company":"宣捷幹細胞","market":"興櫃","industry":"生技醫療","date":"2026-05-20","time":"17:31:15","subject":"公告本公司第三屆審計委員會委員名單","clause":"第6款","fact_date":"2026-05-20","cite_as":"公開資訊觀測站重大訊息：宣捷幹細胞（4724），2026-05-20 17:31，「公告本公司第三屆審計委員會委員名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4724-2026-05-20-1730-1j1cncj","company_id":"4724","company":"宣捷幹細胞","market":"興櫃","industry":"生技醫療","date":"2026-05-20","time":"17:30:43","subject":"公告本公司董事會推選董事長及副董事長","clause":"第6款","fact_date":"2026-05-20","cite_as":"公開資訊觀測站重大訊息：宣捷幹細胞（4724），2026-05-20 17:30，「公告本公司董事會推選董事長及副董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6945-2026-05-20-1730-1jb8ii5","company_id":"6945","company":"圓祥生技","market":"上櫃","industry":"生技醫療","date":"2026-05-20","time":"17:30:33","subject":"公告本公司115年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：圓祥生技（6945），2026-05-20 17:30，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4743-2026-05-20-1730-1jb8ii5","company_id":"4743","company":"合一","market":"上櫃","industry":"生技醫療","date":"2026-05-20","time":"17:30:31","subject":"公告本公司115年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合一（4743），2026-05-20 17:30，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4724-2026-05-20-1729-cl3axh","company_id":"4724","company":"宣捷幹細胞","market":"興櫃","industry":"生技醫療","date":"2026-05-20","time":"17:29:51","subject":"公告本公司115年股東常會通過解除新任董事及其代表人競業禁止之限制","clause":"第22款","fact_date":"2026-05-20","cite_as":"公開資訊觀測站重大訊息：宣捷幹細胞（4724），2026-05-20 17:29，「公告本公司115年股東常會通過解除新任董事及其代表人競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4724-2026-05-20-1728-80fz8l","company_id":"4724","company":"宣捷幹細胞","market":"興櫃","industry":"生技醫療","date":"2026-05-20","time":"17:28:21","subject":"公告本公司115年股東常會提前全面改選董事九席(含獨立董事三席)當選名單","clause":"第6款","fact_date":"2026-05-20","cite_as":"公開資訊觀測站重大訊息：宣捷幹細胞（4724），2026-05-20 17:28，「公告本公司115年股東常會提前全面改選董事九席(含獨立董事三席)當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4724-2026-05-20-1726-1jb8ii5","company_id":"4724","company":"宣捷幹細胞","market":"興櫃","industry":"生技醫療","date":"2026-05-20","time":"17:26:55","subject":"公告本公司115年股東常會重要決議事項","clause":"第15款","fact_date":"2026-05-20","cite_as":"公開資訊觀測站重大訊息：宣捷幹細胞（4724），2026-05-20 17:26，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4746-2026-05-20-1717-10jca0t","company_id":"4746","company":"台耀","market":"上市","industry":"生技醫療","date":"2026-05-20","time":"17:17:54","subject":"本公司受邀參加凱基證券舉辦之法人說明會","clause":"第12款","fact_date":"2026-05-22","cite_as":"公開資訊觀測站重大訊息：台耀（4746），2026-05-20 17:17，「本公司受邀參加凱基證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6986-2026-05-20-1712-1p11qym","company_id":"6986","company":"和迅","market":"上櫃","industry":"生技醫療","date":"2026-05-20","time":"17:12:09","subject":"本公司研發之異體間質幹細胞新藥HeXell-2020，治療穩定型冠狀動脈疾病（CAD）Phase I／IIa）人體臨床試驗，已獲衛生福利部原則同意試驗進行","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：和迅（6986），2026-05-20 17:12，「本公司研發之異體間質幹細胞新藥HeXell-2020，治療穩定型冠狀動脈疾病（CAD）Phase I／IIa）人體臨床試」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4169-2026-05-20-1711-174h673","company_id":"4169","company":"泰宗","market":"上市","industry":"生技醫療","date":"2026-05-20","time":"17:11:47","subject":"更正本公司115年度第一季合併財務報告部分內容誤植","clause":"第51款","fact_date":"2026-05-20","cite_as":"公開資訊觀測站重大訊息：泰宗（4169），2026-05-20 17:11，「更正本公司115年度第一季合併財務報告部分內容誤植」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6580-2026-05-20-1708-3pelwg","company_id":"6580","company":"台睿","market":"興櫃","industry":"生技醫療","date":"2026-05-20","time":"17:08:28","subject":"公告本公司抗癌口服研發中新藥CVM-1118用於中期肝癌之中國第二期臨床試驗完成首位受試者入案。","clause":"第44款","fact_date":"2026-05-20","cite_as":"公開資訊觀測站重大訊息：台睿（6580），2026-05-20 17:08，「公告本公司抗癌口服研發中新藥CVM-1118用於中期肝癌之中國第二期臨床試驗完成首位受試者入案。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6794-2026-05-20-1701-17vkp6y","company_id":"6794","company":"向榮生技","market":"上市","industry":"生技醫療","date":"2026-05-20","time":"17:01:05","subject":"公告本公司董事會委任薪資報酬委員會委員","clause":"第6款","fact_date":"2026-05-20","cite_as":"公開資訊觀測站重大訊息：向榮生技（6794），2026-05-20 17:01，「公告本公司董事會委任薪資報酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6794-2026-05-20-1700-13sk2v0","company_id":"6794","company":"向榮生技","market":"上市","industry":"生技醫療","date":"2026-05-20","time":"17:00:48","subject":"公告本公司審計委員會委員異動","clause":"第6款","fact_date":"2026-05-20","cite_as":"公開資訊觀測站重大訊息：向榮生技（6794），2026-05-20 17:00，「公告本公司審計委員會委員異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6794-2026-05-20-1700-9769qc","company_id":"6794","company":"向榮生技","market":"上市","industry":"生技醫療","date":"2026-05-20","time":"17:00:31","subject":"公告本公司董事會選任董事長","clause":"第6款","fact_date":"2026-05-20","cite_as":"公開資訊觀測站重大訊息：向榮生技（6794），2026-05-20 17:00，「公告本公司董事會選任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6794-2026-05-20-1700-1dk0sd9","company_id":"6794","company":"向榮生技","market":"上市","industry":"生技醫療","date":"2026-05-20","time":"17:00:07","subject":"公告本公司115年股東常會通過解除董事競業禁止之限制","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：向榮生技（6794），2026-05-20 17:00，「公告本公司115年股東常會通過解除董事競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6794-2026-05-20-1659-1jb8ii5","company_id":"6794","company":"向榮生技","market":"上市","industry":"生技醫療","date":"2026-05-20","time":"16:59:39","subject":"公告本公司115年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：向榮生技（6794），2026-05-20 16:59，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6794-2026-05-20-1658-1dvwx20","company_id":"6794","company":"向榮生技","market":"上市","industry":"生技醫療","date":"2026-05-20","time":"16:58:40","subject":"公告本公司115年股東常會董事改選當選名單(含獨立董事)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：向榮生技（6794），2026-05-20 16:58，「公告本公司115年股東常會董事改選當選名單(含獨立董事)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7878-2026-05-20-1650-3nak6n","company_id":"7878","company":"藥祇","market":"興櫃","industry":"生技醫療","date":"2026-05-20","time":"16:50:54","subject":"公告本公司115年股東常會改選董事(含獨立董事)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：藥祇（7878），2026-05-20 16:50，「公告本公司115年股東常會改選董事(含獨立董事)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7878-2026-05-20-1648-9769qc","company_id":"7878","company":"藥祇","market":"興櫃","industry":"生技醫療","date":"2026-05-20","time":"16:48:31","subject":"公告本公司董事會選任董事長","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：藥祇（7878），2026-05-20 16:48，「公告本公司董事會選任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7878-2026-05-20-1647-rzgerl","company_id":"7878","company":"藥祇","market":"興櫃","industry":"生技醫療","date":"2026-05-20","time":"16:47:19","subject":"公告本公司成立審計委員會，監察人自然解任","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：藥祇（7878），2026-05-20 16:47，「公告本公司成立審計委員會，監察人自然解任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7878-2026-05-20-1645-1ayhd6d","company_id":"7878","company":"藥祇","market":"興櫃","industry":"生技醫療","date":"2026-05-20","time":"16:45:30","subject":"公告本公司115年股東常會通過解除本公司新任董事競業禁止限制","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：藥祇（7878），2026-05-20 16:45，「公告本公司115年股東常會通過解除本公司新任董事競業禁止限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2026-05-20-1636-1ike2nd","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2026-05-20","time":"16:36:49","subject":"本公司受邀參加由台新證券舉辦之「台新2026年第二季全球投資論壇」","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2026-05-20 16:36，「本公司受邀參加由台新證券舉辦之「台新2026年第二季全球投資論壇」」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6491-2026-05-20-1636-1feak36","company_id":"6491","company":"晶碩","market":"上市","industry":"生技醫療","date":"2026-05-20","time":"16:36:43","subject":"公告本公司115年除息基準日","clause":"第14款","fact_date":"2026-05-20","cite_as":"公開資訊觀測站重大訊息：晶碩（6491），2026-05-20 16:36，「公告本公司115年除息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7878-2026-05-20-1628-1e5cb69","company_id":"7878","company":"藥祇","market":"興櫃","industry":"生技醫療","date":"2026-05-20","time":"16:28:59","subject":"公告本公司設置審計委員會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：藥祇（7878），2026-05-20 16:28，「公告本公司設置審計委員會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7878-2026-05-20-1627-1jb8ii5","company_id":"7878","company":"藥祇","market":"興櫃","industry":"生技醫療","date":"2026-05-20","time":"16:27:19","subject":"公告本公司115年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：藥祇（7878），2026-05-20 16:27，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7762-2026-05-20-1625-ghdsnc","company_id":"7762","company":"吉晟生","market":"興櫃","industry":"生技醫療","date":"2026-05-20","time":"16:25:27","subject":"公告本公司董事會通過研發主管任命案","clause":"第11款","fact_date":"2026-05-20","cite_as":"公開資訊觀測站重大訊息：吉晟生（7762），2026-05-20 16:25，「公告本公司董事會通過研發主管任命案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6841-2026-05-20-1615-1aq7iqo","company_id":"6841","company":"長佳智能","market":"上櫃","industry":"生技醫療","date":"2026-05-20","time":"16:15:26","subject":"本公司受邀參加元大證券舉辦之法人說明會","clause":"第12款","fact_date":"2026-05-21","cite_as":"公開資訊觀測站重大訊息：長佳智能（6841），2026-05-20 16:15，「本公司受邀參加元大證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6491-2026-05-20-1606-1jb8ii5","company_id":"6491","company":"晶碩","market":"上市","industry":"生技醫療","date":"2026-05-20","time":"16:06:50","subject":"公告本公司115年股東常會重要決議事項","clause":"第18款","fact_date":"2026-05-20","cite_as":"公開資訊觀測站重大訊息：晶碩（6491），2026-05-20 16:06，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2026-05-20-1544-53q3nc","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2026-05-20","time":"15:44:32","subject":"公告本公司董事會決議庫藏股註銷減資事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2026-05-20 15:44，「公告本公司董事會決議庫藏股註銷減資事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2026-05-20-1544-vb9yjo","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2026-05-20","time":"15:44:18","subject":"公告本公司115年度股東會通過解除新任董事(含獨立董事)競業禁止限制案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2026-05-20 15:44，「公告本公司115年度股東會通過解除新任董事(含獨立董事)競業禁止限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2026-05-20-1544-w0teuf","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2026-05-20","time":"15:44:05","subject":"公告本公司董事會決議通過委任第九屆薪資報酬委員會委員","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2026-05-20 15:44，「公告本公司董事會決議通過委任第九屆薪資報酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2026-05-20-1543-tn30yi","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2026-05-20","time":"15:43:54","subject":"公告本公司董事會決議通過委任第九屆審計委員會委員","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2026-05-20 15:43，「公告本公司董事會決議通過委任第九屆審計委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2026-05-20-1543-9769qc","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2026-05-20","time":"15:43:35","subject":"公告本公司董事會選任董事長","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2026-05-20 15:43，「公告本公司董事會選任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2026-05-20-1542-1rayw5g","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2026-05-20","time":"15:42:37","subject":"公告本公司115年股東常會全面改選董事(含獨立董事)當選名單","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2026-05-20 15:42，「公告本公司115年股東常會全面改選董事(含獨立董事)當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2026-05-20-1542-135zcjb","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2026-05-20","time":"15:42:13","subject":"公告本公司115年5月20日股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2026-05-20 15:42，「公告本公司115年5月20日股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6734-2026-05-20-1541-2tip57","company_id":"6734","company":"安盛生","market":"興櫃","industry":"生技醫療","date":"2026-05-20","time":"15:41:27","subject":"公告本公司115年股東常會通過解除新任董事競業禁止限制案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安盛生（6734），2026-05-20 15:41，「公告本公司115年股東常會通過解除新任董事競業禁止限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6734-2026-05-20-1540-1peije0","company_id":"6734","company":"安盛生","market":"興櫃","industry":"生技醫療","date":"2026-05-20","time":"15:40:32","subject":"公告本公司薪酬委員會新任委員名單","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安盛生（6734），2026-05-20 15:40，「公告本公司薪酬委員會新任委員名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6734-2026-05-20-1539-n3db9h","company_id":"6734","company":"安盛生","market":"興櫃","industry":"生技醫療","date":"2026-05-20","time":"15:39:55","subject":"公告本公司審計委員會新任委員名單","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安盛生（6734），2026-05-20 15:39，「公告本公司審計委員會新任委員名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6734-2026-05-20-1539-138n2o8","company_id":"6734","company":"安盛生","market":"興櫃","industry":"生技醫療","date":"2026-05-20","time":"15:39:09","subject":"公告本公司115年股東常會補選獨立董事一席當選名單","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安盛生（6734），2026-05-20 15:39，「公告本公司115年股東常會補選獨立董事一席當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6734-2026-05-20-1537-1jb8ii5","company_id":"6734","company":"安盛生","market":"興櫃","industry":"生技醫療","date":"2026-05-20","time":"15:37:49","subject":"公告本公司115年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安盛生（6734），2026-05-20 15:37，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6926-2026-05-20-1520-1aq7iqo","company_id":"6926","company":"聖安生醫","market":"興櫃","industry":"生技醫療","date":"2026-05-20","time":"15:20:19","subject":"本公司受邀參加元大證券舉辦之法人說明會","clause":"第30款","fact_date":"2026-05-21","cite_as":"公開資訊觀測站重大訊息：聖安生醫（6926），2026-05-20 15:20，「本公司受邀參加元大證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4194-2026-05-20-1506-fafuio","company_id":"4194","company":"禾生技","market":"興櫃","industry":"生技醫療","date":"2026-05-20","time":"15:06:56","subject":"更新-本公司董事任期屆滿全面改選","clause":"第6款","fact_date":"2026-05-20","cite_as":"公開資訊觀測站重大訊息：禾生技（4194），2026-05-20 15:06，「更新-本公司董事任期屆滿全面改選」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4194-2026-05-20-1504-132sxe1","company_id":"4194","company":"禾生技","market":"興櫃","industry":"生技醫療","date":"2026-05-20","time":"15:04:35","subject":"本公司薪資報酬委員會委員任期屆滿","clause":"第6款","fact_date":"2026-05-20","cite_as":"公開資訊觀測站重大訊息：禾生技（4194），2026-05-20 15:04，「本公司薪資報酬委員會委員任期屆滿」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4194-2026-05-20-1503-1kdvt7p","company_id":"4194","company":"禾生技","market":"興櫃","industry":"生技醫療","date":"2026-05-20","time":"15:03:21","subject":"本公司第五屆審計委員會委員","clause":"第6款","fact_date":"2026-05-20","cite_as":"公開資訊觀測站重大訊息：禾生技（4194），2026-05-20 15:03，「本公司第五屆審計委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4194-2026-05-20-1500-1it3x8s","company_id":"4194","company":"禾生技","market":"興櫃","industry":"生技醫療","date":"2026-05-20","time":"15:00:39","subject":"本公司115年股東常會通過解除董事競業行為之限制案","clause":"第22款","fact_date":"2026-05-20","cite_as":"公開資訊觀測站重大訊息：禾生技（4194），2026-05-20 15:00，「本公司115年股東常會通過解除董事競業行為之限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4194-2026-05-20-1459-dwun43","company_id":"4194","company":"禾生技","market":"興櫃","industry":"生技醫療","date":"2026-05-20","time":"14:59:39","subject":"本公司董事任期屆滿全面改選","clause":"第6款","fact_date":"2026-05-20","cite_as":"公開資訊觀測站重大訊息：禾生技（4194），2026-05-20 14:59，「本公司董事任期屆滿全面改選」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6949-2026-05-20-1457-6cq6k2","company_id":"6949","company":"沛爾生醫*-創","market":"上市","industry":"生技醫療","date":"2026-05-20","time":"14:57:01","subject":"公告本公司研發主管異動案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：沛爾生醫*-創（6949），2026-05-20 14:57，「公告本公司研發主管異動案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4194-2026-05-20-1454-15e1v8f","company_id":"4194","company":"禾生技","market":"興櫃","industry":"生技醫療","date":"2026-05-20","time":"14:54:36","subject":"本公司115年股東常會重要決議事項","clause":"第15款","fact_date":"2026-05-20","cite_as":"公開資訊觀測站重大訊息：禾生技（4194），2026-05-20 14:54，「本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4105-2026-05-20-1449-m71431","company_id":"4105","company":"東洋","market":"上櫃","industry":"生技醫療","date":"2026-05-20","time":"14:49:16","subject":"本公司受邀參加凱基證券舉辦之線上法人說明會","clause":"第12款","fact_date":"2026-05-27","cite_as":"公開資訊觀測站重大訊息：東洋（4105），2026-05-20 14:49，「本公司受邀參加凱基證券舉辦之線上法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6785-2026-05-20-1414-182uyqk","company_id":"6785","company":"昱展新藥","market":"上櫃","industry":"生技醫療","date":"2026-05-20","time":"14:14:35","subject":"公告本公司收到「LONG-ACTING INJECTABLE FORMULATIONSOF KETAMINE PAMOATE SALTS」以色列專利核准前通知書。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：昱展新藥（6785），2026-05-20 14:14，「公告本公司收到「LONG-ACTING INJECTABLE FORMULATIONSOF KETAMINE PAMOA」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6931-2026-05-20-1407-bhe9pg","company_id":"6931","company":"青松健康","market":"上市","industry":"生技醫療","date":"2026-05-20","time":"14:07:33","subject":"代重要子公司青松長照社團法人公告現金股利發放日期","clause":"第14款","fact_date":"2026-05-20","cite_as":"公開資訊觀測站重大訊息：青松健康（6931），2026-05-20 14:07，「代重要子公司青松長照社團法人公告現金股利發放日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7881-2026-05-20-1027-1fqkmsr","company_id":"7881","company":"科明","market":"興櫃","industry":"生技醫療","date":"2026-05-20","time":"10:27:42","subject":"澄清媒體報導","clause":"第26款","fact_date":"2026-05-20","cite_as":"公開資訊觀測站重大訊息：科明（7881），2026-05-20 10:27，「澄清媒體報導」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2026-05-20-0859-mofnq9","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2026-05-20","time":"08:59:14","subject":"代重要子公司潤雅生技股份有限公司公告115年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2026-05-20 08:59，「代重要子公司潤雅生技股份有限公司公告115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}